Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Department of Justice
Cantor Fitzgerald
Baxter
Moodys
QuintilesIMS
Citi
Chubb
Medtronic

Generated: June 22, 2018

DrugPatentWatch Database Preview

ANHYDRON Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Anhydron patents expire, and when can generic versions of Anhydron launch?

Anhydron is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in ANHYDRON is cyclothiazide. Additional details are available on the cyclothiazide profile page.
Summary for ANHYDRON
Drug patent expirations by year for ANHYDRON
Synonyms for ANHYDRON
2259-96-3
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-,1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-, 1,1-dioxide
3-(5-bicyclo[2.2.1]hept-2-enyl)-6-chloro-1,1-dioxo-3,4-dihydro-2H-1?^{6},2,4-benzothiadiazine-7-sulfonamide
3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
3-{bicyclo[2.2.1]hept-5-en-2-yl}-6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
3-{bicyclo[2.2.1]hept-5-en-2-yl}-6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
3-Bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide(Clothiazide)
3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #
3-Bicyclo[2.2.1]hept-5-en-2-yl-7-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda*6*-benzo[1,2,4]thiadiazine-6-sulfonic acid amide
6-Chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide
6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiazidiazine-7-sulfonamide-1,1-dioxide
6-chloro-3,4-dihydro-3-(norbornen-2-yl)-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3,4-dihydro-3-(norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
AB00053281_04
AC1L1EQZ
AC1Q6TQ1
AKOS024458615
Anhydron (TN)
Aquirel
BC251589
BDBM50192229
Biomol-NT_000224
BOCUKUHCLICSIY-UHFFFAOYSA-N
BPBio1_001320
BRD-A38675539-001-01-0
BRN 0722843
C 9847
C12685
CAS-2259-96-3
CCG-204416
CHEBI:31448
CHEMBL61593
Ciclotiazida
Ciclotiazida [INN-Spanish]
Ciclotiazide
Ciclotiazide [DCIT]
cyclothiazide
Cyclothiazide (JAN/USAN/INN)
Cyclothiazide (mixture of isomers)
Cyclothiazide [USAN:INN:BAN]
Cyclothiazidum
Cyclothiazidum [INN-Latin]
D01256
D03CNS
DB00606
DivK1c_000904
Doburil
DSSTox_CID_2871
DSSTox_GSID_22871
DSSTox_RID_76767
DTXSID3022871
EINECS 218-859-7
EU-0100321
Fluidil
FT-0665417
GTPL4167
HE006045
HE326625
HMS2093A19
HMS2236K04
HMS3261A03
HMS3266L17
HMS3373E04
HMS502N06
HSDB 3310
IDI1_000904
J-014778
KBio1_000904
KBioGR_000519
Lilly 35,483
Lilly 35483
Lopac0_000321
LP00321
LS-40445
MDi 193
MLS001077326
MolPort-003-666-800
NCGC00015288-04
NCGC00015288-05
NCGC00015288-06
NCGC00015288-07
NCGC00015288-09
NCGC00022985-02
NCGC00024745-02
NCGC00024745-03
NCGC00024745-04
NCGC00261006-01
NINDS_000904
NSC-758431
NSC758431
P71U09G5BW
Pharmakon1600-01503263
Renazide
SBI-0050309.P003
SCHEMBL121096
SMR000653479
Spectrum4_000050
Spectrum5_001639
SR-01000075796
SR-01000075796-1
Tox21_110124
Tox21_110124_1
Tox21_500321
UNII-P71U09G5BW
Valmiran

US Patents and Regulatory Information for ANHYDRON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly ANHYDRON cyclothiazide TABLET;ORAL 013157-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Colorcon
Johnson and Johnson
US Army
Fuji
Citi
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.